A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variantsChang Yi Wang, Thomas P. Monath, Juin-Hua Huang et al.|DOAJ (DOAJ: Directory of Open Access Journals)|2022Cited by 76
A Randomized First‐in‐Human Study With UB‐312, a UBITh® α‐Synuclein Peptide VaccineHui Jing Yu, Jean‐Cosme Dodart|Movement Disorders|2022Cited by 51
Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trialPepijn Eijsvogel, Jean‐Cosme Dodart, Pinaki Misra et al.|Nature Medicine|2024Cited by 38